A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers

Status:
Completed

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

To determine whether the bioavailability of the controlled-release test formulation is at least as high as that for the commercial reference drug.